$AMS Balance Sheet | Understand Stock

$AMS

$1.25 +$0.00 (0.0%) After hours

$AMS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable, net of allowance for credit losses of $1,110,000 and $980,000 at June 30, 2026 and December 31, 2025, respectively
Tax receivables
Other receivables
Due from expired customer contract
VAT credits
Prepaid maintenance
Prepaid expenses and other current assets
Total current assets
Medical equipment and facilities
Office equipment
Construction in progress
Property, Plant and Equipment, Gross, Excluding Land
Accumulated depreciation and amortization
Property and equipment, net
Land
Goodwill
Intangible asset
Right of use assets, net
Other assets
Total assets
Current liabilities:
Accounts payable
Employee compensation and benefits
Other accrued liabilities
Asset retirement obligations
Related party liabilities
Asset retirement obligations, related party (includes $125,000 and $250,000 non-related party at June 30, 2026 and December 31, 2025, respectively)
Income taxes payable
Current portion deferred revenue
Current portion of lease liabilities
Line of credit
Current portion of long-term debt, net
Current portion of finance leases
Total current liabilities
Long-term lease liabilities, less current portion
LONG-TERM DEBT, net, less current portion
LONG-TERM FINANCE LEASES, less current portion
DEFERRED REVENUE, less current portion
Deferred income taxes
Total liabilities

Shareholders' equity:
Common stock, no par value (10,000,000 authorized; 6,079,000 and 6,049,000 shares issued and outstanding at March 31, 2022 and at December 31, 2021
Common stock, no par value (10,000,000 authorized shares; Issued and outstanding shares - 6,625,000 at June 30, 2026 and 6,575,000 at December 31, 2025)
Additional paid-in capital
Retained earnings
Total equity-American Shared Hospital Services
Non-controlling interests in subsidiaries
Total shareholders' equity
Total liabilities and shareholders' equity

Comments